A graduate of the University of Washington (UW) biostatistics program, Robert Wellman, MS, joined the Kaiser Permanente Washington Health Research Institute (KPWHRI) Biostatistics Unit in 2009. His work spans a diverse collection of topics including mental health, pharmacoepidemiology, postmarketing drug safety surveillance, obesity, diagnostic test accuracy, back pain, and breast cancer. Prior to this, he spent 5 years in the Biostatistics Core at the UW Center for AIDS Research.
Causal inference; longitudinal data; diagnostic and screening test accuracy; clinical trials; survival analysis: rare disease outcomes; nonparametrics; missing data; electronic data; distributed data; statistical computing
Biostatistics; HIV/AIDS; vaccine safety
Biostatistics; clinical trials; back pain
Biostatistics; bariatric surgery
Biostatistics; breast cancer; effects of chemotherapy; accuracy of automated data; screening test accuracy; advanced imaging
Biostatistics; pharmacoepidemiology; postmarketing drug safety surveillance; big data; electronic health record and claims data
Biostatistics; suicide risk prediction, machine learning
Delate T, Bowles EJ, Pardee R, Wellman RD, Habel LA, Yood MU, Nekhlyudov L, Goddard KA, Davis RL, McCarty CA, Onitilo AA, Feigelson HS, Freml J, Wagner E. Validity of eight integrated healthcare delivery organizations' administrative clinical data to capture breast cancer chemotherapy exposure. Cancer Epidemiol Biomarkers Prev. 2012 Apr;21(4):673-80. Epub 2012 Feb 15. PubMed
Stekler JD, Wellman R, Holte S, Maenza J, Stevens CE, Corey L, Collier AC. Are there benefits to starting antiretroviral therapy during primary HIV infection? Conclusions from the Seattle Primary Infection Cohort vary by control group. Int J STD AIDS. 2012;23(3):201-6. PubMed
Cook AJ, Tiwari RC, Wellman RD, Heckbert SR, Li L, Heagerty P, Marsh T, Nelson JC. Statistical approaches to group sequential monitoring of postmarket safety surveillance data: current state of the art for use in the Mini-Sentinel pilot. Pharmacoepidemiol Drug Saf. 2012;21 Suppl 1:72-81. doi: 10.1002/pds.2320. PubMed
Bowles EA, Wellman R, Delate T, Allen L, Feigelson HS, Yood MU, Davis R, Nekhlyudov L, McCarty C, Habel L, Magid D, Onitilo A, Freedman A, Wagner E. Cardiotoxic chemotherapy is associated with increased heart failure risk among women with breast cancer in the Cancer Research Network. Clin Med Res. 2011;9(3-4):148. PubMed
Delate T, Bowles E, Pardee R, Wellman R, Habel L, Yood M, Nekhlyudov L, Goddard K, Davis R, McCarty C, Onitilo A, Feigelson H, Freml J, Wagner E. Validity of HMO administrative data for breast cancer chemotherapy exposure. Clin Med Res. 2011;9(3-4):146. PubMed
Models that are easier to explain, use could have better uptake in health care settings.
A study among KP members with sleep problems and osteoarthritis shows promise for overcoming obstacles to treatment.
Watch video on latest results from PCORnet Bariatric Study. (Spoiler alert: Bypass, not sleeve.)